Ortek Therapeutics

Mr. Goldberg is the founder and president of Ortek Therapeutics, Inc., and he has over 35 years of experience in the healthcare industry. Mr. Goldberg was directly responsible for the clinical development, FDA clearance, commercial scale up, manufacturing and commercialization for the Ortek-ECD, and executed all aspects for the commercialization of BasicBites. Mr. Goldberg was directly responsible for the development and FDA clearance of Ortek's two earlier prescription toothpaste products that were sold to Colgate Palmolive. Under his leadership, Ortek also executed a highly successful sublicense agreement with one of the world's largest oral care companies. Prior to founding Ortek, Mr. Goldberg was the co-founder, Executive Vice President and Director of Noven Pharmaceuticals now a subsidiary of Hisamitsu Pharmaceutical Company. Noven was a two-person startup specialty transdermal drug delivery company that grew to a fully integrated; highly profitable publicly traded company that was sold for $428 million in cash. Mr. Goldberg oversaw Noven's private and public financings, and he was instrumental in executing licensing agreements with major pharmaceutical companies.

Steven Sablotsky has been a director of Ortek since its inception. Mr. Sablotsky has over 40 years of experience in the pharmaceutical industry and has invented and co-invented several prescription drug products that have achieved in excess of $1 billion in sales. Mr. Sablotsky, along with Mitchell Goldberg, co-founded Noven Pharmaceuticals, Inc., a specialty pharmaceutical company (now a subsidiary of Hisamitsu Pharmaceutical Company) involved in the development, manufacturing, and marketing of advanced transdermal drug delivery products. Under his leadership, Noven grew from a two-person startup to a fully integrated; highly profitable publicly traded company. Prior to founding Noven, Mr. Sablotsky was employed at Key Pharmaceuticals, Inc., now owned by Merck & Co. Earlier in his career, he was responsible for the process development of the first commercially viable artificial kidney. Most recently, he was the founder of Ocean Research Corporation where he designed and built a globally capable expedition vessel with the mission to discover pharmacologically active compounds by using (the first ever), oceanic real-time genome sequencing.

Anne Nugent Guignon, RDH, MPH, CSP is a highly sought-after international speaker, prolific author, and RDH Magazine feature writer. She is a recognized expert on the oral microbiome, ergonomics, salivary dysfunction, cariology and erosive tooth wear, and employment law matters. Despite her accomplishments, Anne’s clinician heart is always focused on making clinical practice better, easier, and more rewarding. In 2015 she was awarded the CSP, the National Speakers Association’s highest earned credential. Anne is a visionary thinker who has a passion for sharing information. She has received numerous accolades for mentoring, research, and guiding those in healthcare and client services.

Dr. George Freedman is a founder and past president, American Academy of Cosmetic Dentistry, a co-founder, Canadian Academy for Esthetic Dentistry, Regent and Fellow, International Academy for Dental Facial Esthetics, and a Diplomate and Chair of the American Board of Aesthetic Dentistry. He is Adjunct Professor of Dental Medicine, Western University, Pomona, California and Professor and Program Director, BPP University, London, UK, MClinDent Programme in Restorative and Cosmetic Dentistry. He is an author of 14 textbooks, and is an internationally renowned lecturer and author of 900 dental articles. He is the International Editor-in-Chief of Dental Tribune and 3D Dentistry, and is on the editorial Boards of Dentistry Today, Oral Health and Dental Asia.

Howard S. Glazer, DDS, FAGD is a Fellow and Past President of the Academy of General Dentistry, and former Assistant Clinical Professor in Dentistry at the Albert Einstein College of Medicine (Bronx, NY), presently he is an Attending Dentist at Englewood Hospital (NJ). He is a Fellow of the American College of Dentists; International College of Dentists; American Society for Dental Aesthetics, the American Academy of Forensic Sciences, and a Diplomat of the American Board of Aesthetic Dentistry. Additionally, Dr. Glazer is the Deputy Chief Forensic Dental Consultant to the Office of Chief Medical Examiner, City of New York. He lectures nationally and internationally and is a frequent author and has been published worldwide.

Mr. Confessore is a senior biomedical and electrical engineer and a member of the Translational Oral Biology and Pathology department at Stony Brook University School of Dental Medicine. Mr. Confessore is a co-inventor of the Ortek-ECD. Mr. Confessore conceived the theory and electrical design for the Ortek-ECD, and provided valuable input for clinical development and regulatory support. Mr. Confessore has worked at Stony Brook University for the past 46 years. During his tenure he contributed to numerous research and development projects and designed, developed, modified equipment and facilities for research programs within the school.

Mr. Johnson has been an advisor to Ortek Therapeutics for over 15 years. He has over 30 years of healthcare industry investment banking experience at firms such as First Boston, Kidder Peabody, Piper Jaffray and WR Hambrecht. In addition, he has also held key healthcare industry executive roles including CEO, COO and CFO. Mr. Johnson received his B.A. degree in Biology from the University of Missouri and his M.B.A. degree from Harvard Business School.

Michelle Strange is a practicing traveling registered dental hygienist (RDH) with a career spanning over 20 years. Michelle's primary focus and passion lie in patient care's educational aspects, which she curates for consumers and dental professionals. Michelle has achieved her Master's degree in Dental Hygiene Education focusing on interdisciplinary collaboration. She continues to invest in ongoing education, gaining relevant certifications such as her Certificate in Dental Infection Prevention and Control. Presently, Michelle is a co-founder of Level Up Infection Prevention, A Tale of Two Hygienists Podcast, the Client Success Manager for TeleDent by Mouthwatch, owner of MichelleStrangeRDH.com and TheRoamingDentalHygienist.com.

Shannon Nanne, RDH has spent most of her professional career focused on creating awareness of oral cancer and its side effects. She was the executive director of the Global Oral Cancer Forum 2016. She’s authored articles in several publications and has been a key opinion leader for several oral care companies including Ortek. Mrs. Nanne has sat on the Corporate Council for Dimensions of Dental Hygiene for almost two decades and has held an executive board position in the Cleveland Dental Hygiene Association for more than 15 years. Shannon is currently the director of professional relations and education for Curaden, a Swiss oral healthcare company.